150 related articles for article (PubMed ID: 36870031)
1. Cost-effectiveness analysis of (accelerated) pre-operative versus (conventional) post-operative radiotherapy for patients with oral cavity cancer in Sweden.
Silfverschiöld M; Carlwig K; Jarl J; Greiff L; Nilsson P; Wennerberg J; Zackrisson B; Östensson E; Sjövall J
Eur J Health Econ; 2024 Feb; 25(1):177-185. PubMed ID: 36870031
[TBL] [Abstract][Full Text] [Related]
2. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
3. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of combined cognitive and vocational rehabilitation in patients with mild-to-moderate TBI: results from a randomized controlled trial.
Howe EI; Andelic N; Fure SCR; Røe C; Søberg HL; Hellstrøm T; Spjelkavik Ø; Enehaug H; Lu J; Ugelstad H; Løvstad M; Aas E
BMC Health Serv Res; 2022 Feb; 22(1):185. PubMed ID: 35151285
[TBL] [Abstract][Full Text] [Related]
5. Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost-utility analysis alongside a randomized HYPO-RT-PC trial.
Sun S; Jonsson H; Salén KG; Andén M; Beckman L; Fransson P
Eur J Health Econ; 2023 Mar; 24(2):237-246. PubMed ID: 35587847
[TBL] [Abstract][Full Text] [Related]
6. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of voice rehabilitation for patients with laryngeal cancer: a randomized controlled study.
Johansson M; Finizia C; Persson J; Tuomi L
Support Care Cancer; 2020 Nov; 28(11):5203-5211. PubMed ID: 32078058
[TBL] [Abstract][Full Text] [Related]
8. [Incremental cost effectiveness of multifocal cataract surgery].
Pagel N; Dick HB; Krummenauer F
Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFIT.
Zhou K; Renouf M; Perrocheau G; Magné N; Latorzeff I; Pommier P; Créhange G; Paumier A; Bera G; Martin J; Catton C; Bellanger M; Supiot S
Radiother Oncol; 2022 Aug; 173():306-312. PubMed ID: 35772576
[TBL] [Abstract][Full Text] [Related]
10. Epidural analgesia during labour, routinely or on request: a cost-effectiveness analysis.
Bonouvrié K; van den Bosch A; Roumen FJ; van Kuijk SM; Nijhuis JG; Evers SM; Wassen MM
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():23-31. PubMed ID: 27816738
[TBL] [Abstract][Full Text] [Related]
11. Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity - The ARTSCAN 2 study.
Wennerberg J; Gebre-Medhin M; Nilsson P; Brun E; Kjellén E; Carlwig K; Reizenstein J; Kristiansson S; Söderkvist K; Wahlgren M; Zackrisson B;
Radiother Oncol; 2022 Jan; 166():26-32. PubMed ID: 34793864
[TBL] [Abstract][Full Text] [Related]
12. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
[TBL] [Abstract][Full Text] [Related]
14. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
Pharmacoeconomics; 2005; 23(4):377-93. PubMed ID: 15853437
[TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness of trastuzumab in the treatment of early stages breast cancer patients, in Portugal].
Macedo A; Monteiro I; Andrade S; Cirrincione A; Ray J
Acta Med Port; 2010; 23(3):475-82. PubMed ID: 20654267
[TBL] [Abstract][Full Text] [Related]
16. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
[TBL] [Abstract][Full Text] [Related]
18. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.
Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
Pharmacoeconomics; 2005; 23(4):395-420. PubMed ID: 15853438
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial.
Lindgren P; Jönsson B; Yusuf S
J Intern Med; 2004 May; 255(5):562-70. PubMed ID: 15078498
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Real-World Administration of Concomitant
Thronicke A; Reinhold T; von Trott P; Matthes H; Schad F
Evid Based Complement Alternat Med; 2020; 2020():3543568. PubMed ID: 32256640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]